Description

Edrecolomab is a monoclonal antibody with the CAS Registry Number 156586-89-9, representing a significant therapeutic agent in oncology research and development. Its primary value lies in its targeted mechanism of action against specific tumor-associated antigens, offering a pathway for precise cancer immunotherapy. This product is essential for pharmaceutical R&D laboratories, biotechnology companies, and academic institutions focused on developing novel monoclonal antibody-based treatments for various cancers.

Application

• Oncology Research & Drug Development: As a key reference standard and active pharmaceutical ingredient (API) in pre-clinical and clinical-stage research for cancer therapies.
• Biopharmaceutical Manufacturing: Serves as a critical intermediate or finished API in the production of monoclonal antibody therapeutics under Good Manufacturing Practice (GMP) conditions.
• Immunological Studies: Used in vitro and in vivo to study antibody-dependent cellular cytotoxicity (ADCC) and other immune-mediated anti-tumor effects.
• Diagnostic Reagent Development: Employed in the creation of assay controls, calibration standards, and diagnostic kits for cancer biomarker detection.
• Academic & Contract Research: Supports fundamental research into tumor biology, metastasis, and the mechanisms of targeted immunotherapy in university and CRO settings.

Basic Information

Product Name	Edrecolomab
CAS No.	156586-89-9
Molecular Formula	Contact for details
Molecular Weight	Contact for details
Synonyms	Monoclonal Antibody 17-1A; Panorex; MAb 17-1A; Edrecolomabum; Anti-EpCAM Monoclonal Antibody; EpCAM Antibody; 17-1A Antibody; IUPAC: Immunoglobulin G1, anti-(human epithelial cell adhesion molecule) (human-mouse monoclonal 17-1A γ1-chain), disulfide with human-mouse monoclonal 17-1A κ-chain, dimer
EINECS	Contact for details

Quality Control

Our Edrecolomab is manufactured and controlled under a stringent quality management system. Each batch undergoes comprehensive analytical testing, including purity assessment by HPLC, identity confirmation, and biological activity assays, to ensure it meets the high standards required for pharmaceutical research and development. Certificates of Analysis (COA) detailing all specifications and test results are provided to guarantee traceability, consistency, and compliance with your project requirements.

Storage

Preserve in a tightly closed container, protected from light. Store at 2-8°C. This product is hygroscopic (moisture-sensitive) and should be handled under controlled conditions to prevent degradation. For long-term storage, consider aliquoting and freezing at -20°C or below under appropriate conditions.

Specification

Item	Specification
Appearance	White to off-white lyophilized powder or clear solution
Identification (HPLC/MS)	Conforms to reference standard
Purity (HPLC)	≥ 95.0%
Protein Content (UV)	As per COA
Biological Activity (Cell-based assay)	As per COA
Endotoxin (LAL)	< 1.0 EU/mg
Sterility (Membrane Filtration)	Sterile

Note: Specifications can be tailored. Please contact us for the detailed technical data sheet of a specific grade.